Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Biocon Limited

    Client Virtual Booth

    BIOCON LIMITED

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Biocon
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    Hosur Road,Electronics City,Bangalore
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocon.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company-beta/162713/
    Twitter
    Twitter
    https://twitter.com/Bioconlimited

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    ListList of Products
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Everolimus

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    29651
    Active
    EVEROLIMUS (WITH 0.2% BHT)
    2015-09-30
    CEP/COS

    Found CEP/COS

    R0-CEP 2022-235 - Rev 00
    Valid
    Everolimus, 0.2% BHT-II
    2022-08-26
    Japanese DMF

    Close JDMF

    Written Confirmation

    Caution WC

    Indian CDSCO WC-0100
    Expired
    Everolimus (IH)
    2019-07-22
    Application Number
    29651
    R0-CEP 2022-235 - Rev 00
    Indian CDSCO WC-0100
    Status
    Active
    Fees Paid
    Reviewed
    Valid
     
    Expired
    2022-07-02
    Filing Details
    EVEROLIMUS (WITH 0.2% BHT)
    Everolimus, 0.2% BHT-II
    Everolimus (IH)
    Issue/Submission Date
    2015-09-30
    2022-08-26
    2019-07-22
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Everolimus

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    29657
    Active
    EVEROLIMUS
    2015-09-30
    CEP/COS

    Found CEP/COS

    R0-CEP 2022-143 - Rev 00
    Valid
    Everolimus, 2% BHT-II
    2022-08-31
    Japanese DMF

    Close JDMF

    Written Confirmation

    Caution WC

    Indian CDSCO WC-0100A7
    Expired
    Everolimus EP
    2020-08-17
    Application Number
    29657
    R0-CEP 2022-143 - Rev 00
    Indian CDSCO WC-0100A7
    Status
    Active
    Fees Paid
    Reviewed
    Valid
     
    Expired
    2022-07-02
    Filing Details
    EVEROLIMUS
    Everolimus, 2% BHT-II
    Everolimus EP
    Issue/Submission Date
    2015-09-30
    2022-08-31
    2020-08-17
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Everolimus

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    31950
    Active
    EVEROLIMUS (2% BHT)
    2018-05-02
    CEP/COS

    Found CEP/COS

    R0-CEP 2019-323 - Rev 00
    Valid
    Everolimus, 0.2% BHT
    2022-01-31
    Japanese DMF

    Close JDMF

    Written Confirmation

    Close WC

    Application Number
    31950
    R0-CEP 2019-323 - Rev 00
    Status
    Active
    Fees Paid
    Reviewed
    Valid
     
    Filing Details
    EVEROLIMUS (2% BHT)
    Everolimus, 0.2% BHT
    Issue/Submission Date
    2018-05-02
    2022-01-31
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Everolimus

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    35688
    Active
    EVEROLIMUS PREMIX 2%
    2021-04-01
    CEP/COS

    Found CEP/COS

    R0-CEP 2020-072 - Rev 01
    Valid
    Everolimus, 2% BHT
    2023-04-19
    Japanese DMF

    Close JDMF

    Written Confirmation

    Close WC

    Application Number
    35688
    R0-CEP 2020-072 - Rev 01
    Status
    Active
    Fees Paid
    Reviewed
    Valid
     
    Filing Details
    EVEROLIMUS PREMIX 2%
    Everolimus, 2% BHT
    Issue/Submission Date
    2021-04-01
    2023-04-19
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search